| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1
|
Qian, Wenbin
|
|
2007
|
31 |
Supplement 1 |
p. 329-339
11 p.
|
artikel
|
| 2 |
Brefeldin A triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cells
|
Wlodkowic, Donald
|
|
2007
|
31 |
Supplement 1 |
p. 1687-1700
14 p.
|
artikel
|
| 3 |
C016 A previous diagnosis of myelodysplastic syndrome has no influence on the clinical outcome of elderly patients with acute myeloid leukaemia
|
Ferrara, F.
|
|
2007
|
31 |
Supplement 1 |
p. S31-
1 p.
|
artikel
|
| 4 |
Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha
|
Lehner, Manfred
|
|
2007
|
31 |
Supplement 1 |
p. 1729-1735
7 p.
|
artikel
|
| 5 |
CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC
|
Perez-Chacon, Gema
|
|
2007
|
31 |
Supplement 1 |
p. 183-193
11 p.
|
artikel
|
| 6 |
C030 Hematopoietic stem cell transplantation after a myeloablative conditioning regimen in children with refractory cytopenia: results of a retrospective analysis from the EWOG-MDS group
|
Locatelli, F.
|
|
2007
|
31 |
Supplement 1 |
p. S39-
1 p.
|
artikel
|
| 7 |
Chemokine system and tissue infiltration in aggressive NK-cell leukemia
|
Makishima, Hideki
|
|
2007
|
31 |
Supplement 1 |
p. 1237-1245
9 p.
|
artikel
|
| 8 |
Clinical relevance of soluble HLA-I and β2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease
|
Albitar, Maher
|
|
2007
|
31 |
Supplement 1 |
p. 139-145
7 p.
|
artikel
|
| 9 |
Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors
|
Bao, Fei
|
|
2007
|
31 |
Supplement 1 |
p. 1511-1520
10 p.
|
artikel
|
| 10 |
Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia
|
Chen, Jiann-Shiuh
|
|
2007
|
31 |
Supplement 1 |
p. 1351-1357
7 p.
|
artikel
|
| 11 |
Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol
|
Zhou, Xia
|
|
2007
|
31 |
Supplement 1 |
p. 1259-1265
7 p.
|
artikel
|
| 12 |
C002 Polymorphisms of DNA-repair and detoxification enzymes in myelodysplastic syndromes
|
Voso, M.T.
|
|
2007
|
31 |
Supplement 1 |
p. S23-S24
2 p.
|
artikel
|
| 13 |
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression
|
Kline, Michael
|
|
2007
|
31 |
Supplement 1 |
p. 591-598
8 p.
|
artikel
|
| 14 |
Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia
|
Fiegl, Michael
|
|
2007
|
31 |
Supplement 1 |
p. 531-539
9 p.
|
artikel
|
| 15 |
Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor
|
Komura, Naoyuki
|
|
2007
|
31 |
Supplement 1 |
p. 301-313
13 p.
|
artikel
|
| 16 |
Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders
|
Lorand-Metze, Irene
|
|
2007
|
31 |
Supplement 1 |
p. 147-155
9 p.
|
artikel
|
| 17 |
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis
|
Rohner, Andreas
|
|
2007
|
31 |
Supplement 1 |
p. 1393-1402
10 p.
|
artikel
|
| 18 |
35 Do histone deacetylase inhibitors have a place in the treatment of myelodysplastic syndromes?
|
Gore, S.D.
|
|
2007
|
31 |
Supplement 1 |
p. S21-
1 p.
|
artikel
|
| 19 |
Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia
|
Cheng, Yun-Chih
|
|
2007
|
31 |
Supplement 1 |
p. 1403-1411
9 p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
2007
|
31 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 21 |
Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
|
Qian, Si-Xuan
|
|
2007
|
31 |
Supplement 1 |
p. 1383-1388
6 p.
|
artikel
|
| 22 |
Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells
|
Liesveld, Jane L.
|
|
2007
|
31 |
Supplement 1 |
p. 1553-1563
11 p.
|
artikel
|
| 23 |
1 Epidemiologic features in myelodysplastic syndromes
|
Germing, U.
|
|
2007
|
31 |
Supplement 1 |
p. S1-
1 p.
|
artikel
|
| 24 |
Erythroleukaemia, diabetes insipidus and hypophyseal damage: Two case reports
|
Piccin, A.
|
|
2007
|
31 |
Supplement 1 |
p. 1135-1139
5 p.
|
artikel
|
| 25 |
E15 Therapy for chronic lymphocytic leukemia (CLL): how to proceed
|
Jakšić, B.
|
|
2007
|
31 |
Supplement 1 |
p. S27-S29
3 p.
|
artikel
|
| 26 |
E12 Therapy for T-cell non-Hodgkin's lymphoma
|
Vose, J.M.
|
|
2007
|
31 |
Supplement 1 |
p. S22-S23
2 p.
|
artikel
|
| 27 |
Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes
|
Jiang, Yixing
|
|
2007
|
31 |
Supplement 1 |
p. 541-545
5 p.
|
artikel
|
| 28 |
Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement
|
Suminoe, Aiko
|
|
2007
|
31 |
Supplement 1 |
p. 1437-1440
4 p.
|
artikel
|
| 29 |
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia
|
Browning, Rebekah L.
|
|
2007
|
31 |
Supplement 1 |
p. 1737-1740
4 p.
|
artikel
|
| 30 |
Expressions of the VLA-4, LFA-1 and Mac-1 integrins in eosinophil migration in a case of chronic eosinophilic leukaemia
|
Lima, Carmen S.P.
|
|
2007
|
31 |
Supplement 1 |
p. 695-697
3 p.
|
artikel
|
| 31 |
Genetic variations in benzene metabolism and susceptibility to multiple myeloma
|
Lincz, Lisa F.
|
|
2007
|
31 |
Supplement 1 |
p. 759-763
5 p.
|
artikel
|
| 32 |
Global cytokine analysis in myeloproliferative disorders
|
Ho, Ching-Liang
|
|
2007
|
31 |
Supplement 1 |
p. 1389-1392
4 p.
|
artikel
|
| 33 |
Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
|
Gattermann, Norbert
|
|
2007
|
31 |
Supplement 1 |
p. S10-S15
6 p.
|
artikel
|
| 34 |
HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells
|
Oliver, Lisa
|
|
2007
|
31 |
Supplement 1 |
p. 859-863
5 p.
|
artikel
|
| 35 |
Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL)
|
Takasaki, Yumi
|
|
2007
|
31 |
Supplement 1 |
p. 751-757
7 p.
|
artikel
|
| 36 |
Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy
|
Leitch, Heather A.
|
|
2007
|
31 |
Supplement 1 |
p. S7-S9
3 p.
|
artikel
|
| 37 |
5 Insights into the molecular pathogenesis of myelodysplastic syndromes
|
Nimer, S.D.
|
|
2007
|
31 |
Supplement 1 |
p. S3-S4
2 p.
|
artikel
|
| 38 |
Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells
|
Yang, Sheng-Huei
|
|
2007
|
31 |
Supplement 1 |
p. 1413-1420
8 p.
|
artikel
|
| 39 |
Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells
|
Ikezoe, Takayuki
|
|
2007
|
31 |
Supplement 1 |
p. 673-682
10 p.
|
artikel
|
| 40 |
Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1α-25-dihydroxyvitamin D3, as differentiating agent
|
Orciuolo, Enrico
|
|
2007
|
31 |
Supplement 1 |
p. 1321-1323
3 p.
|
artikel
|
| 41 |
Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study
|
Zhang, Daohai
|
|
2007
|
31 |
Supplement 1 |
p. 75-82
8 p.
|
artikel
|
| 42 |
22 Myelodysplastic syndromes: molecular markers
|
Wainscoat, J.S.
|
|
2007
|
31 |
Supplement 1 |
p. S13-
1 p.
|
artikel
|
| 43 |
Myeloma bone disease: Pathogenetic mechanisms and clinical assessment
|
Silvestris, Franco
|
|
2007
|
31 |
Supplement 1 |
p. 129-138
10 p.
|
artikel
|
| 44 |
Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway
|
Wang, Xiaojian
|
|
2007
|
31 |
Supplement 1 |
p. 653-660
8 p.
|
artikel
|
| 45 |
OP41 Chronic graft versus host disease: new approaches for transplant greatest challenges
|
Pavletic, S.Z.
|
|
2007
|
31 |
Supplement 1 |
p. S52-
1 p.
|
artikel
|
| 46 |
OP14 Design and analysis of clinical trials in acute leukemia: review of a 25-year experience
|
Suciu, S.
|
|
2007
|
31 |
Supplement 1 |
p. S39-
1 p.
|
artikel
|
| 47 |
OP55 Management of relapsed indolent lymphoma
|
Cabanillas, F.
|
|
2007
|
31 |
Supplement 1 |
p. S58-S59
2 p.
|
artikel
|
| 48 |
OP24 Myelodysplastic syndrome management in Slovakia
|
Mistrik, M.
|
|
2007
|
31 |
Supplement 1 |
p. S44-
1 p.
|
artikel
|
| 49 |
OP38 Reduced intensity conditioning hematopoietic cell transplants in elderly patients with AML
|
Niederwieser, D.
|
|
2007
|
31 |
Supplement 1 |
p. S50-
1 p.
|
artikel
|
| 50 |
P001 Acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma carrying mutated CCAAT/enhancer-binding protein alpha
|
Fuchs, O.
|
|
2007
|
31 |
Supplement 1 |
p. S65-
1 p.
|
artikel
|
| 51 |
P042 Alteration in immune-effector cells in bone marrow of myelodysplastic syndrome patients
|
Alfinito, F.
|
|
2007
|
31 |
Supplement 1 |
p. S63-S64
2 p.
|
artikel
|
| 52 |
P145 A meta-analysis of the published studies and the long-term results of a large personal experience form the basis for an appropriate use of thalidomide in myelodysplastic syndromes
|
Musto, P.
|
|
2007
|
31 |
Supplement 1 |
p. S120-
1 p.
|
artikel
|
| 53 |
P159 A reduced-intensity conditioning regimen for children with refractory cytopenia transplanted from an unrelated donor
|
Strahm, B.
|
|
2007
|
31 |
Supplement 1 |
p. S127-
1 p.
|
artikel
|
| 54 |
P151 Azacitidine in combination with EPO+G-CSF and valproic acid rapidly determines hematological improvement in pretreated non responsive IPSS INT-1 MDS patients
|
Santini, V.
|
|
2007
|
31 |
Supplement 1 |
p. S123-
1 p.
|
artikel
|
| 55 |
P090 B7.1 expression on blasts in myelodysplastic syndromes
|
Tamura, H.
|
|
2007
|
31 |
Supplement 1 |
p. S88-S89
2 p.
|
artikel
|
| 56 |
P004 Changes in thymic recent output function in patients with acute myeloid leukemia
|
Li, Y.
|
|
2007
|
31 |
Supplement 1 |
p. S66-S67
2 p.
|
artikel
|
| 57 |
P015 Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorised as unclassified (MDS/MPD-U) by WHO classification
|
Breccia, M.
|
|
2007
|
31 |
Supplement 1 |
p. S48-S49
2 p.
|
artikel
|
| 58 |
P153 Clinical effects of 5-azacitidine five days/monthly schedule in three symptomatic low-risk (IPSS: 0-1) myelodysplastic patients
|
Fili, C.
|
|
2007
|
31 |
Supplement 1 |
p. S124-
1 p.
|
artikel
|
| 59 |
P121 Coping with myelodysplastic syndromes (MDS): lessons learned from those living with the disease
|
Thomas, M.L.
|
|
2007
|
31 |
Supplement 1 |
p. S105-
1 p.
|
artikel
|
| 60 |
P131 Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
|
Kühne, F.
|
|
2007
|
31 |
Supplement 1 |
p. S111-
1 p.
|
artikel
|
| 61 |
P118 Detection of cardiac iron by T2* MRI in transfusion dependent patients with acquired anemias
|
Deplano, S.
|
|
2007
|
31 |
Supplement 1 |
p. S103-S104
2 p.
|
artikel
|
| 62 |
P029 Early progenitor cells antigens and apoptosis in patients with secondary myelodysplasia exposed to ionizing radiation after Chernobyl accident
|
Ilyenko, I.
|
|
2007
|
31 |
Supplement 1 |
p. S56-S57
2 p.
|
artikel
|
| 63 |
P082 Enhancement of immune and hematopoietic reconstitution by IL-7 following experimental bone marrow transplantation in a murine model may be mediated by IL-2 and RAG-1 activation
|
Abdul-Hai, A.
|
|
2007
|
31 |
Supplement 1 |
p. S100-S101
2 p.
|
artikel
|
| 64 |
P073 Gene expression profiling in the myelodysplastic syndrome: patients with intermediate 1 versus higher risk
|
Kracmarova, A.
|
|
2007
|
31 |
Supplement 1 |
p. S79-S80
2 p.
|
artikel
|
| 65 |
Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies
|
Gojo, Ivana
|
|
2007
|
31 |
Supplement 1 |
p. 1165-1173
9 p.
|
artikel
|
| 66 |
P135 Has treatment with EPO+/-G-CSF an impact on progression to AML and survival in low/int-1-risk MDS? A comparison between French-EPO patients and the IMRAW database
|
Park, S.
|
|
2007
|
31 |
Supplement 1 |
p. S113-
1 p.
|
artikel
|
| 67 |
P001 Incidence of myelodysplastic syndromes in the United States medicare population
|
Goldberg, S.L.
|
|
2007
|
31 |
Supplement 1 |
p. S41-
1 p.
|
artikel
|
| 68 |
P056 Is the increased apoptosis a cause of impaired CD34+ B-cell precursors production in myelodysplastic syndromes?
|
Sandes, A.F.
|
|
2007
|
31 |
Supplement 1 |
p. S70-S71
2 p.
|
artikel
|
| 69 |
P035 JAK2 V617F mutation and the clinical features in myeloproliferative disorders
|
Radić Antolic, M.
|
|
2007
|
31 |
Supplement 1 |
p. S80-
1 p.
|
artikel
|
| 70 |
P059 Long-term results of CHOP/CHOP like chemotherapy ± rituximab in patients with diffuse large B-cell lymphoma (DLBCL)
|
Mihaljevic, B.
|
|
2007
|
31 |
Supplement 1 |
p. S91-
1 p.
|
artikel
|
| 71 |
P090 Molecular detection of Epstein-Barr virus in patients with bone marrow transplantation
|
Vince, A.
|
|
2007
|
31 |
Supplement 1 |
p. S104-S105
2 p.
|
artikel
|
| 72 |
P018 mTOR inhibitor rapamycin interacts synergistically with farnesyltransferase inhibitor FTI-277 to induce growth inhibition in human leukemia cells
|
Min, Y.H.
|
|
2007
|
31 |
Supplement 1 |
p. S72-S73
2 p.
|
artikel
|
| 73 |
PO025 Comparison of CFU-GM in patients with chronic myelomonocytic leukemia 1 and 2 (according to WHO classification), with typical myelodysplastic syndromes (MDS) and myeloproliferative diseases (MPD)
|
Wiater, E.
|
|
2007
|
31 |
Supplement 1 |
p. S141-
1 p.
|
artikel
|
| 74 |
PO033 Results of the treatment with erythropoietin in myelodysplastic syndrome in 25 patients from a single Romanian center
|
Tatic, A.
|
|
2007
|
31 |
Supplement 1 |
p. S144-S145
2 p.
|
artikel
|
| 75 |
PO016 Secondary leukemia in a patient with multiple myeloma treated by a standard protocol of chemotherapy and autologous bone marrow transplantation
|
Lorand-Metze, I.
|
|
2007
|
31 |
Supplement 1 |
p. S136-S137
2 p.
|
artikel
|
| 76 |
PO002 The clinical, hematological and morphological profile of patients with myelodysplastic syndromes: a single institution experienc
|
Demirkan, F.
|
|
2007
|
31 |
Supplement 1 |
p. S129-
1 p.
|
artikel
|
| 77 |
P076 Primary low grade marginal zone B-cell uterine lymphoma: a case report
|
López López, J.A.
|
|
2007
|
31 |
Supplement 1 |
p. S98-
1 p.
|
artikel
|
| 78 |
P104 Prognostic role of transfusion requirement in myelodysplastic syndromes
|
Salvi, F.
|
|
2007
|
31 |
Supplement 1 |
p. S96-
1 p.
|
artikel
|
| 79 |
P062 Results of RCHOP6 or RCHOP8 study in the treatment of patients with diffuse large B-cell lymphoma – single institution study
|
Trajkova, S.
|
|
2007
|
31 |
Supplement 1 |
p. S92-
1 p.
|
artikel
|
| 80 |
Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index
|
Yu, Margaret K.
|
|
2007
|
31 |
Supplement 1 |
p. 773-777
5 p.
|
artikel
|
| 81 |
Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders
|
Shimada, Akira
|
|
2007
|
31 |
Supplement 1 |
p. 1199-1203
5 p.
|
artikel
|
| 82 |
P049 Serum level of intercellular adhesion molecule-1 (ICAM-1) in patients with malignant lymphoma
|
Abdelrazik, N.
|
|
2007
|
31 |
Supplement 1 |
p. S86-S87
2 p.
|
artikel
|
| 83 |
P039 The EGFR-inhibitor erlotinib exhibits various off-target effects in MDS and AML
|
Boehrer, S.
|
|
2007
|
31 |
Supplement 1 |
p. S62-
1 p.
|
artikel
|
| 84 |
P087 Use of multiparametric flow cytometry analysis (six-color) for the detection of leukemia associated immunophenotypes (LAIP) in myelodysplastic syndromes (MDS)
|
Campos, L.
|
|
2007
|
31 |
Supplement 1 |
p. S87-
1 p.
|
artikel
|
| 85 |
P093 Zevalin-BEAM conditioning therapy for autologous peripheral stem cell transplantation (PSCT) in patients with follicular non-Hodgkin lymphoma
|
Reményi, G.
|
|
2007
|
31 |
Supplement 1 |
p. S106-
1 p.
|
artikel
|
| 86 |
Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia
|
Spanaki, A.
|
|
2007
|
31 |
Supplement 1 |
p. 639-642
4 p.
|
artikel
|
| 87 |
RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma
|
Nagy, Bálint
|
|
2007
|
31 |
Supplement 1 |
p. 1595-1597
3 p.
|
artikel
|
| 88 |
Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome
|
Campos, Paula de Melo
|
|
2007
|
31 |
Supplement 1 |
p. 853-857
5 p.
|
artikel
|
| 89 |
Reduction of intracellular pH inhibits the expression of VEGF in K562 cells after targeted inhibition of the Na+/H+ exchanger
|
He, Bingyan
|
|
2007
|
31 |
Supplement 1 |
p. 507-514
8 p.
|
artikel
|
| 90 |
Regulation of RUNX1/AML1 during the G2/M transition
|
Wang, Suiquan
|
|
2007
|
31 |
Supplement 1 |
p. 839-851
13 p.
|
artikel
|
| 91 |
Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia
|
Hattori, Hiroyoshi
|
|
2007
|
31 |
Supplement 1 |
p. 1633-1640
8 p.
|
artikel
|
| 92 |
Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid
|
Beneš, Petr
|
|
2007
|
31 |
Supplement 1 |
p. 1421-1431
11 p.
|
artikel
|
| 93 |
Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-γ/interleukin-1β-dependent apoptosis of endothelial cells: Implications in the etiology of retinoic acid syndrome
|
Gao, Yin
|
|
2007
|
31 |
Supplement 1 |
p. 455-463
9 p.
|
artikel
|
| 94 |
Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines
|
Berg, Tobias
|
|
2007
|
31 |
Supplement 1 |
p. 497-506
10 p.
|
artikel
|
| 95 |
Role of glycosylphosphatidylinositol-specific phospholipase D in the homing of umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cells
|
Song, Kui
|
|
2007
|
31 |
Supplement 1 |
p. 1701-1707
7 p.
|
artikel
|
| 96 |
S05 Chelation therapy in transfusional iron overload: Exjade efficacy and safety
|
Cappellini, M.D.
|
|
2007
|
31 |
Supplement 1 |
p. S115-
1 p.
|
artikel
|
| 97 |
Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia
|
Au, Wing-Yan
|
|
2007
|
31 |
Supplement 1 |
p. 105-108
4 p.
|
artikel
|
| 98 |
Survivin and EPR-1 expression in acute leukemias: Prognostic significance and review of the literature
|
Oto, Ozgur Akin
|
|
2007
|
31 |
Supplement 1 |
p. 1495-1501
7 p.
|
artikel
|
| 99 |
Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells
|
Kimura, Noriko
|
|
2007
|
31 |
Supplement 1 |
p. 1529-1535
7 p.
|
artikel
|
| 100 |
The fundamental contribution of Jan C. Waldenström to the discovery and study of the so-called “Waldenström macroglobulinemia”
|
Ribatti, Domenico
|
|
2007
|
31 |
Supplement 1 |
p. 435-438
4 p.
|
artikel
|
| 101 |
The suppressor of cytokine signalling-1 (SOCS-1) gene is overexpressed in Philadelphia chromosome negative chronic myeloproliferative disorders
|
Bock, Oliver
|
|
2007
|
31 |
Supplement 1 |
p. 799-803
5 p.
|
artikel
|
| 102 |
t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma
|
Niitsu, Nozomi
|
|
2007
|
31 |
Supplement 1 |
p. 707-711
5 p.
|
artikel
|
| 103 |
Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia
|
Yetgin, Sevgi
|
|
2007
|
31 |
Supplement 1 |
p. 493-496
4 p.
|
artikel
|
| 104 |
Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells
|
Shen, Hui-Ling
|
|
2007
|
31 |
Supplement 1 |
p. 515-521
7 p.
|
artikel
|
| 105 |
WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders
|
Michiels, Jan Jacques
|
|
2007
|
31 |
Supplement 1 |
p. 1031-1038
8 p.
|
artikel
|
Tijdschrift beschrijving